ProQuest Associates IV LLC
10% owner at EAGLE PHARMACEUTICALS, INC.; 10% owner at Immune Design Corp.
- Sold, on record
- $49.2M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Apr 25, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- EAGLE PHARMACEUTICALS, INC.10% owner
- Immune Design Corp.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- EAGLE PHARMACEUTICALS, INC.583,918 shares
- Immune Design Corp.270,788 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Immune Design Corp.Plan not statedJul 29, 2014 2014
Sold 208,334 shares at $12.00 ($2.5M)
ProQuest Associates IV LLC, 10% owner
Sold 8.3% of holdings ($30.2M position)2.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale Immune Design Corp.Plan not statedApr 1, 2015 +246 days
Sold 62,454 shares at $26.37 ($1.6M)
ProQuest Associates IV LLC, 10% owner
Sold 2.6% of holdings ($63.7M position)2.4M shares leftFiling
- 3 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not statedSep 29, 2016 +547 days
Sold 77,900 shares at $70.04 ($5.5M)
ProQuest Associates IV LLC, 10% owner
Sold 1.7% of holdings ($313M position)4.4M shares leftFirst sale on recordFiling
- 4 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not statedNov 4, 2016 +36 days
Sold 245,770 shares at $71.02 ($17.5M)
ProQuest Associates IV LLC, 10% owner
Sold 5.6% of holdings ($314M position)4.2M shares leftFiling
- 5 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not statedNov 11, 2016 +7 days
Sold 34,486 shares at $85.15 ($2.9M)
ProQuest Associates IV LLC, 10% owner
Sold 0.9% of holdings ($339M position)3.9M shares leftFiling
- 6 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not statedJan 4, 2017 +54 days
Sold 65,114 shares at $85.16 ($5.5M)
ProQuest Associates IV LLC, 10% owner
Sold 1.7% of holdings ($336M position)3.9M shares left0.8x usual sizeFiling
- 7 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualMar 29, 2017 +84 days
Sold 106,468 shares at $83.01 ($8.8M)
ProQuest Associates IV LLC, 10% owner
Sold 82.1% of holdings ($10.8M position)23,274 shares left1.5x usual sizeFiling
- 8 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualApr 25, 2017 +27 days
Sold 54,180 shares at $88.38 ($4.8M)
ProQuest Associates IV LLC, 10% owner
Sold 88.9% of holdings ($5.4M position)6,777 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2017 | Apr 27, 2017 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 54,180 | $4.8M | 88.9% | Unusual | SEC |
| Mar 29, 2017 | Mar 29, 2017 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 106,468 | $8.8M | 82.1% | Unusual | SEC |
| Jan 4, 2017 | Jan 6, 2017 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 65,114 | $5.5M | 1.7% | Plan not stated | SEC |
| Nov 11, 2016 | Nov 14, 2016 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 34,486 | $2.9M | 0.9% | Plan not stated | SEC |
| Nov 4, 2016 | Nov 4, 2016 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 245,770 | $17.5M | 5.6% | Plan not stated | SEC |
| Sep 29, 2016 | Sep 30, 2016 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 77,900 | $5.5M | 1.7% | Plan not stated | SEC |
| Apr 1, 2015 | Apr 2, 2015 | Immune Design Corp. | 10% owner | Form 4 sale | 62,454 | $1.6M | 2.6% | Plan not stated | SEC |
| Jul 29, 2014 | Jul 31, 2014 | Immune Design Corp. | 10% owner | Form 4 sale | 208,334 | $2.5M | 8.3% | Plan not stated | SEC |